CenturyLink Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

CenturyLink Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,404	Closed	-$240K	–	269
2015 Q3	$240K	Sell	3,404 -935	-22%	-$91.4K	0.08%	209
2015 Q2	$482K	Buy	4,339 +2,293	+112%	+$247K	0.16%	172
2015 Q1	$193K	Buy	+2,046	New	+$229K	0.06%	231

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CenturyLink Investment Management's AGIO Position: Q4 2015 in Review

CenturyLink Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2015, closing a stake of 3,404 shares — an estimated $240K sold.

CenturyLink Investment Management first reported a position in AGIO in Q1 2015 and held it in 3 quarters. The position peaked at $482K in Q2 2015. 144 funds tracked by Wall St. Rank hold AGIO as of Q4 2015.

CenturyLink Investment Management reported no remaining Agios Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
CenturyLink Investment Management sold 3,404 Agios Pharmaceuticals shares in Q4 2015, an estimated $240K.
CenturyLink Investment Management first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 3 quarters.
CenturyLink Investment Management's Agios Pharmaceuticals position peaked at $482K in Q2 2015.
144 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2015.

Based on CenturyLink Investment Management's 13F filing for Q4 2015, filed 25 Jan 2016.